2001
DOI: 10.1055/s-2001-19030
|View full text |Cite
|
Sign up to set email alerts
|

Cholangiocyte Biology and Cystic Fibrosis Liver Disease

Abstract: Cystic fibrosis (CF) is one of the most common inherited diseases in the white population. The disease results from mutations in the gene for the cystic fibrosis transmembrane conductance regulator (CFTR). How this gene defect leads to the clinical manifestations of the disease, however, is not entirely clear. CFTR functions as a Cl(-) channel in the apical membrane of most secretory epithelia, including biliary epithelial cells, or cholangiocytes. In cholangiocytes, CFTR appears to be an important determinant… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
90
1
11

Year Published

2002
2002
2015
2015

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 117 publications
(104 citation statements)
references
References 143 publications
1
90
1
11
Order By: Relevance
“…Furthermore, many of the effects of cAMP on bile formation appear to be mediated by ATP release into the duct lumen and subsequent activation of apical P2 receptors (9,10). These general findings are consistent with the clinical observation that only 10 -20% of patients with cystic fibrosis (CF) develop clinically significant liver disease despite absent or abnormal CFTR in biliary epithelium (11,12). Furthermore, in cells with the CF phenotype, activation of P2 receptors still elicits potent secretory responses (13,14).…”
supporting
confidence: 75%
“…Furthermore, many of the effects of cAMP on bile formation appear to be mediated by ATP release into the duct lumen and subsequent activation of apical P2 receptors (9,10). These general findings are consistent with the clinical observation that only 10 -20% of patients with cystic fibrosis (CF) develop clinically significant liver disease despite absent or abnormal CFTR in biliary epithelium (11,12). Furthermore, in cells with the CF phenotype, activation of P2 receptors still elicits potent secretory responses (13,14).…”
supporting
confidence: 75%
“…Elevated levels in liver function tests (LFTs: alanine transaminase, aspartate transaminase, γ-glutamyltransferase, and bilirubin) are commonly observed in the majority of newborn CF infants (41,42,57) and newborn CF ferrets (40). Neonatal elevations in LFTs observed in CF infants are generally thought to reflect cholestasis due to thickening of bile (42,57,58). However, when liver biopsies were evaluated in CF neonates, there was no direct correlation between LFTs and histologic cholestasis (41).…”
Section: Discussionmentioning
confidence: 99%
“…Fatty liver disease is not uncommon in human CF (41,58), and liver dysfunction (including fatty liver) is often associated with insulin resistance and abnormal glucose metabolism in humans and mice (49,59). Fatty liver (or steatosis) is characterized by excessive triglyceride deposition.…”
Section: Discussionmentioning
confidence: 99%
“…In kurzer Zeit konnten mittlerweile bereits hunderte Polymorphismen in den Transportergenen BSEP und MRP2 der gesunden Bevöl-kerung identifiziert werden, deren pathogenetische Bedeutung bislang unklar ist [70,71]. Auch auf der Ebene der Gallengangszellen ist es in den letzten Jahren durch Entdeckung von Mutationen im CFTR-Gen bei zystischer Fibrose (am häufigsten (⌬F508 mit Trafficking-Defekt) und im JAG1-Gen bei Alagille-Syndrom zu Fortschritten im Verständnis der molekularen Pathogenese der Cholestase gekommen [72,73]. Die molekulargenetische Diagnostik könnte in Zukunft zur routinemäßi-gen Identifikation hereditärer Cholestasesyndrome beitragen.…”
Section: Molekulargenetische Diagnostikunclassified